1Division of Urology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Identifying men at high risk for prostate cancer treatment failure is crucial for personalized care and clinical trial enrollment. Research is evolving to include traditional factors and newer genetic insights for better prognostication.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: